|
|
 |
| Metabasis is a biopharmaceutical company focused on the discovery,
development and commercialization of novel drugs by applying its proprietary
technologies, scientific expertise and unique capabilities for targeting
the liver and liver pathways. The Company has established a broad
pipeline of product candidates and advanced research programs targeting
large markets with significant unmet needs. Metabasis' product pipeline
represents drug candidates indicated for the treatment of metabolic
diseases such as hyperlipidemia and diabetes, among others. Additionally,
our pipeline includes drug candidates for the treatment of liver diseases
such as hepatitis and primary liver cancer which the company plans
to license. All product candidates were developed internally using
proprietary technologies including the Company's NuMimetic and HepDirect
technologies. |
|
August 7, 2008
Metabasis Therapeutics Announces Second Quarter 2008 Financial
Results and Comments on Significant Company Accomplishments
more
August 7, 2008
Metabasis Therapeutics Announces Collaboration with Roche
to Develop Liver-Targeted Compounds for the Treatment of Hepatitis
C more
|
|
| | |
